Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Aytu Biopharma Inc (AYTU)

Aytu Biopharma Inc (AYTU)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0100 (-0.80%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2200
Day High
1.3500
Open 1.3500
Previous Close 1.2500 1.2500
Volume 30,900 30,900
Avg Vol 43,440 43,440
Stochastic %K 35.48% 35.48%
Weighted Alpha -62.29 -62.29
5-Day Change +0.0351 (+2.91%) +0.0351 (+2.91%)
52-Week Range 1.1500 - 3.4475 1.1500 - 3.4475
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,712
  • Shares Outstanding, K 6,170
  • Annual Sales, $ 81,000 K
  • Annual Income, $ -15,840 K
  • EBIT $ -4 M
  • EBITDA $ 5 M
  • 60-Month Beta -1.63
  • Price/Sales 0.09
  • Price/Cash Flow N/A
  • Price/Book 0.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +83,350.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +7.83%
on 03/19/25
Period Open: 1.3500
1.3800 -10.14%
on 02/25/25
-0.1100 (-8.15%)
since 02/21/25
3-Month
1.1500 +7.83%
on 03/19/25
Period Open: 1.3800
1.9300 -35.75%
on 01/17/25
-0.1400 (-10.14%)
since 12/20/24
52-Week
1.1500 +7.83%
on 03/19/25
Period Open: 2.9800
3.4475 -64.03%
on 05/14/24
-1.7400 (-58.39%)
since 03/21/24

Most Recent Stories

More News
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Net income of $0.8 million

AYTU : 1.2400 (-0.80%)
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

DENVER, CO / ACCESS Newswire / February 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that CEO,...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma Disclosure Notification

DENVER, CO / ACCESSWIRE / December 3, 2024 / SUMMARY NOTICE OF PENDENCY OF DERIVATIVE ACTION, AGREEMENT OF SETTLEMENT AND RELEASE WITH RESPECT TO CERTAIN PARTIES, AND SETTLEMENT HEARING IN THE COURT OF...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced it ranked...

AYTU : 1.2400 (-0.80%)
Alaska Air clears a big hurdle in its proposed merger with Hawaiian Airlines

Alaska Air is one step closer to acquiring Hawaiian Airlines after the U.S. Department of Justice chose not to challenge the $1.9 billion deal that the carriers say will create a company better able to...

MIRA : 1.2800 (+4.92%)
NTGR : 23.63 (-2.32%)
AYTU : 1.2400 (-0.80%)
$SPX : 5,667.56 (+0.08%)
$DOWI : 41,985.35 (+0.08%)
$IUXX : 19,753.97 (+0.39%)
Aytu BioPharma to Participate in the Canaccord Genuity 42nd Annual Growth Conference

ENGLEWOOD, CO / ACCESSWIRE / July 26, 2022 / Aytu BioPharma, Inc. (the "Company") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome

ENGLEWOOD, CO / ACCESSWIRE / July 20, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the initiation of...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma Announces the Appointment of Vivian Liu to the Company's Board of Directors

ENGLEWOOD, CO / ACCESSWIRE / June 29, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the appointment of...

AYTU : 1.2400 (-0.80%)
Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference

ENGLEWOOD, CO / ACCESSWIRE / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the company...

AYTU : 1.2400 (-0.80%)

Business Summary

Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual...

See More

Key Turning Points

3rd Resistance Point 1.4500
2nd Resistance Point 1.4000
1st Resistance Point 1.3200
Last Price 1.2400
1st Support Level 1.1900
2nd Support Level 1.1400
3rd Support Level 1.0600

See More

52-Week High 3.4475
Fibonacci 61.8% 2.5699
Fibonacci 50% 2.2987
Fibonacci 38.2% 2.0276
Last Price 1.2400
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals